Arrhythmias & electrophysiology

Atrial Arrhythmia Burden (SMURDEN) After Ablation of Atrial Fibrillation (AF) Is Associated With Improvement in Quality of Life

JACC Clin ElectrophysiolPublished Secondary analysis of the DECAAF II randomised trial

Authors' conclusion

Patients who experienced AF recurrence reported diminished symptom and QoL improvements. SMURDEN emerged as the most significant predictor of symptom improvement and was the only independent factor associated with a lack of improvement or worsening of symptoms.

Study context

Population
Patients with persistent AF with symptom severity scores before and after ablation
Participants
750 patients
Comparison
Magnetic resonance imaging (MRI)-guided fibrosis ablation plus pulmonary vein isolation (PVI) vs PVI alone
Primary endpoint
Determinants of symptom and QoL change (AFSS and SF-36)
Follow-up
3 and 12 months postablation
Methodological detailsprespecified analysis
  • Prespecified analysis

Primary result

As reported in the abstract

Predictors of symptom/QoL improvement
SMURDEN correlated with quality of life (QoL) improvement and was the only predictor of no improvement or symptom worsening
R = 0.31; P < 0.001
Patients without AF recurrence: greater improvement in most SF-36 and Atrial Fibrillation Symptom Severity (AFSS) subcategories
P < 0.05

Further findings

OutcomePVIMRI-guided fibrosis ablationP value
AFSS symptom score, baselineMean12.3 (SD 8.2)12.0 (SD 8.0)P = 0.670
AFSS symptom score improvementSymptoms improved in both arms6.8 ± 0.57.3 ± 0.5P = 0.114

Original publication

Atrial Arrhythmia Burden (SMURDEN) After Ablation of AF Is Associated With Improvement in Quality of Life. JACC Clin Electrophysiol. Published 29 August 2025. doi:10.1016/j.jacep.2025.07.011

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.